ABSTRACT
Fibromyalgia syndrome (FMS) is characterized by widespread pain and abnormal tenderness. The pain must be above and below the waist, on the right and left sides of the body, and in some axial region, all for longer than 3 months. 1 report the successful metabolic treatment of a hypothyroid FMS patient and a euthyroid FMS patient. Before beginning treatment, both patients met the American College of Rheumatology (ACR) criteria for FMS. By the 8th week of treatment, the euthyroid patient no longer met the ACR criteria; by the 14th week of treatment, the hypothyroid patient no longer met the criteria. The treatment protocol is multidisciplinary. Recovery of these two patients, managed at an independent clinical site, supports the effectiveness of the treatment itself for both hypothyroid and euthyroid FMS. The outcomes of the two cases are consistent with those reported in 3 systematic open trials and 3 double-blind trials. The metabolic therapy protocol developed by researchers at the Fibromyalgia Research Foundation appears to be a highly effective treatment for both euthyroid and hypothyroid FMS.